FDA Physician Labeling Final Rule At OMB

"Requirements on Content and Format of Labeling for Human Prescription Drugs and Biological Products" final rule is under review at the Office of Management & Budget. The 2000 proposed rule included a "highlights" section and combined warnings and precautions sections.